===Amyris (AMRS) files for bankruptcy in US

 

(Reuters) - Biotech firm Amyris Inc on Wednesday said it has filed for Chapter 11 bankruptcy in a U.S. court and is planning to sell its consumer brands to improve the company's liquidity position.

Amyris said it has secured a $190 million financing commitment to support day-to-day operations, adding that its entities outside the U.S. are not included in the bankruptcy proceedings.

In a filing with the Delaware bankruptcy court, the company listed estimated assets in the range of $500 million to $1 billion and liabilities in the range of $1 billon to $10 billion.

"Restructuring is intended to improve the Company's cost structure, capital structure, and liquidity position while streamlining Amyris' business portfolio to focus on its core competencies in R&D...," the company said.

In June, Amyris said it was cutting jobs to reduce costs and appointed Han Kieftenbeld as new interim CEO, following the resignation of John Melo.

Amyris had also initiated a "strategic transformation program" in June and secured a term loan facility of up to $50 million.

Long trade : Amyris (AMRS) +40% (6/20)

• May 29: #7, 11, 29, 30 ; vol.2.0M

 

This week's biggest % winners & losers : April 15 - 19, 2019 (wk 16)

The following are this week's top percentage gainers and losers, categorized by sectors (over $300 mln market cap and 100K average daily volume).

This week's top 20 % gainers

• Healthcare: ARQL (6.54 +17.63%), CTLT (43.97 +12%)
• Industrials: ADSW (32.83 +20.97%), BGG (14.1 +12.35%), PATK (55.13 +12.08%), MRTN (20.44 +11.69%)
• Materials: AMRS  (5.02  +74.91%)
• Consumer Discretionary: NEW (13.14 +31.93%), ADNT (25.91 +24.99%), TLRD (8.23 +10.62%), GOOS (52.68 +9.89%)
• Information Technology: QCOM (79.89 +40.28%), EFII (37.51 +27.59%), ADTN (16.59 +15.29%)
• Financials: QD (6.60 +15.59%)
• Energy: MDR (9.92 +10.22%)
• Consumer Staples: SFS (6.52 +18.33%), PPC (25.82 +11.15%), ELF (12.96 +10.96%), MGPI (87.3 +10.31%),

This week's top 20 % losers

• Healthcare: APHA (7.65 -24.26%), THC (23.41 -19.3%), INSP (47.07 -18.58%), COLL (13.52 -18.51%), MDGL (105.56 -16.77%), MNK (18.23 -16.18%), TBIO (9.99 -16.05%), STAA (31.21 -14.94%), IONS (72.99 -13.73%), PRQR (11.34 -13.37%)
• Consumer Discretionary: SNBR (39.16 -19.72%), SKX (31.60  -8.17%)
• Information Technology: STNE (26.51 -24.79%), CEVA (23.3 -19.04%)
• Financials: EHTH (54.76 -17.26%)
• Energy: ROAN (4.43 -22.82%), ALTM (5.00 -14.53%), GPOR (6.69 -13.57%)

Long trade : Amyris (AMRS) +70% (4/19)

a.  Apr. 12;  vol. 4.M
b. Apr. 15;  #7, 22, 26, 97  vol. 6.8.M

 

Amyris (AMRS) reported earnings on Tue 13 Nov 2018 (a/h)

** charts after earnings **

 

Amyris misses by $0.46, misses on revs

• Reports Q3 (Sep) loss of $0.63 per share, excluding non-recurring items, $0.46 worse than the two analyst estimate of ($0.17); revenues fell 38.4% year/year to $14.9 mln vs the $46.72 mln two analyst estimate. 
• "We are pleased with the rapid ramp up of our new, zero calorie sweetener product and our continued strong recurring revenue growth," said John Melo, President and CEO of Amyris. "However, we are very disappointed with the volatility of the Vitamin E market and its direct impact on our third quarter revenue. Some of this shortfall is expected be made up with our core market revenue performance through year end." Continued Melo, "While the unpredictable nature of the Vitamin E market and our royalty is disappointing, we are very pleased by the strong growth of our Clean Beauty business, the early demand for our zero calorie sweetener and for the better than planned growth of our ingredients business. Our recurring revenue has been doubling year on year and we are on pace to deliver for the fourth quarter at an annualized rate of about $200 million in recurring revenue.

Earnings this week : November 12 - 16, 18 (wk 46)

Earnings confirmed to report this week:

Monday (Nov 12) 

• Morning: ACB ACM ATHM
• Afternoon:  APU EB EQH EXPI FOCS HUYA KRNT NVGS TDW UGI VERI YRD YY

Tuesday (Nov 13)

• Morning:   AAP ARMK BZH CAE DQ EPC EYE GDS HD TSN
• Afternoon:  AMRS CDLX CWK HI HOLI MTSI ORIG PETQ REZI SSTI SVMK SWCH TLRY VREX WIX

Wednesday (Nov 14)

• Morning:  APRN BPMP CGC CVIA GOOS LX M MTOR QIWI
• Afternoon: CPA CSCO NTAP NTES PRSP SFS VIPS WPM ZTO

Thursday (Nov 15)

• Morning: BERY BRC CSIQ CUB DDS ENR JCP LXFT MANU SPH SR TK TNK WMT WUBA
• Afternoon: AMAT CRMT DWCH ESE GLOB HTHT JWN MATW  NGVC  NVDA POST SCVL SONO WAIR WSM

Friday (Nov 16)

• Morning: HP FRO  VIAB

Amyris (AMRS) — is it a buy?

short ratio: 19.60

12/28/18:  Is AMRS a buy?

 

• 4 years later: